TFA
EW icon

Transamerica Financial Advisors’s Edwards Lifesciences EW Stock Holding History

Transamerica Financial Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33K Buy
365
+232
+174% +$19.4K ﹤0.01% 765
2026
Q1 		$10.7K Buy
133
+98
+280% +$8.08K ﹤0.01% 912
2025
Q4 		$2.98K Buy
35
+14
+67% +$1.15K ﹤0.01% 1055
2025
Q3 		$1.63K Buy
+21
New +$1.64K ﹤0.01% 1082
2020
Q3 		– Sell
-1
Closed -$1K – 262
2020
Q2 		$1K Buy
+1
New +$71 ﹤0.01% 375
2016
Q2 		– Sell
-11,124
Closed -$328K – 486
2016
Q1 		$328K Buy
11,124
+7,548
+211% +$208K 0.03% 264
2015
Q4 		$95K Hold
3,576
– – 0.01% 346
2015
Q3 		$85K Sell
3,576
-24
-0.7% -$579 0.01% 335
2015
Q2 		$86K Sell
3,600
-17,220
-83% -$389K 0.01% 396
2015
Q1 		$495K Sell
20,820
-144
-0.7% -$3.23K 0.03% 230
2014
Q4 		$446K Buy
20,964
+20,952
+174,600% +$421K 0.04% 195
2014
Q3 		$1K Hold
12
– – ﹤0.01% 606
2014
Q2 		$1K Sell
12
-32,652
-100% -$443K ﹤0.01% 614
2014
Q1 		$404K Buy
+32,664
New +$377K 0.04% 179

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Transamerica Financial Advisors's EW Position: Q2 2026 in Review

Transamerica Financial Advisors increased its Edwards Lifesciences (EW) stake by 174% in Q2 2026, buying an estimated $19.4K and bringing the position to 365 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #765.

Transamerica Financial Advisors first reported a position in EW in Q1 2014 and has held it in 14 quarters since. The position peaked at $495K in Q1 2015. 1,330 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Transamerica Financial Advisors held 365 shares of Edwards Lifesciences worth $33K as of Q2 2026.
  • Transamerica Financial Advisors bought 232 Edwards Lifesciences shares in Q2 2026, an estimated $19.4K.
  • Edwards Lifesciences made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #765 holding.
  • Transamerica Financial Advisors first reported a position in Edwards Lifesciences in Q1 2014 and has held it in 14 quarters since.
  • Transamerica Financial Advisors's Edwards Lifesciences position peaked at $495K in Q1 2015.
  • 1,330 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.